Join us on March 19th, 14:00 CET for a live session for life sciences commercial and marketing leaders.
Most commercial teams face revenue targets that increase each year. Pipeline volume grows, yet forecast accuracy stays flat. Sales enters deals after the shortlist forms. Pricing pressure increases. Marketing reports lead volume but struggles to tie activity to revenue.
The root cause is not lead volume. It is how you define your addressable market, select target accounts, and align marketing and sales to the same revenue metrics.
Teams that increase win rate and deal size influence buying criteria before vendor selection. They enter opportunities before requirements are locked and competitors are favored.
What you will learn
✅ Define your addressable market using revenue potential, buying centers, and active demand signals.
✅ Build a target account list based on Ideal Buying Profiles.
✅ Align marketing and sales to revenue metrics.
✅ Develop persona-based messaging tied to buyer stage and decision risk.
✅ Shift from reacting to inbound demand to defining evaluation criteria.
When buying groups define requirements before speaking to vendors, the first credible voice shapes the shortlist. Early engagement increases win rate and protects margin.
Attend this session to learn how to align marketing and sales around revenue outcomes and enter more qualified deals before competitors are positioned.
